This antibody targets TMOD1, a protein that inhibits both elongation and depolymerization of actin filaments at their pointed ends. The Tmod/tropomyosin (TM) complex contributes to the formation of short actin protofilaments, influencing the structure of the membrane cytoskeleton. TMOD1 may play a significant role in regulating actin filament organization through preferential binding to specific tropomyosin isoforms at their N-termini.